3-methyl-5-[(2S)-2-pyrrolidinyl]-1,2,4-oxadiazole hydrochloride, 95.0%, 5g

Ethyl 6-bromo-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridine-1-carboxylate, 95+%, 250mg

6-ETHYL-7H-PYRROLO[2,3-D]PYRIMIDINE-2,4-DIOL, 95.0%, 250mg

Strontium Fluoride100g

4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide, 98.0%, 1g

2-(5-TETRAZOLYL)ETHANAMINE HCL, 95.0%, 250mg

(R)-2-((tert-Butoxycarbonyl)amino)-5-(cyclohexyloxy)-5-oxopentanoic acid, 95.0%, 100g

4-Bromo-1-methyl-1H-indole, 95.0%, 5g

5-tert-Butyl-4H-1,2,4-triazol-3-amine, = 95% (NMR), 100mg

TERT-BUTYL 3-(2-(DIMETHYLAMINO)ETHYLAMINO)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 1g

Recipiente de reacción con brida plana cilíndrico, graduado (2) Fondo plano, DN 60, 65 mm, Altura, 75 mm, 1 Pieza

3,5-Difluoro-4-iodo-pyridine-2-carbonitrile, 98%, 10g

tert-Butyl trans-4-ethynylcyclohexylcarbamate, 95%, 250mg